![Ragnar Linder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ragnar Linder
Directeur/Membre du Conseil chez
ALZECURE PHARMA AB
Fortune : 68 386 $ au 31/07/2026
Profil
Ragnar Linder is the founder of Pygargus AB. Mr. Linder is currently an Independent Director at Perpetua Medical AB since 2019, an Independent Director at AlzeCure Pharma AB since 2017, and a Director at both 3D Trace AB and Tegnér Biotech Consulting AB. Former positions include Chief Executive Officer at Amgen AB from 2001 to 2005, Non-Executive Director at Newron Pharmaceuticals SpA, and Director roles at Asarina Pharma AB, Umecrine Cognition AB, and R Linder Holding AB. Education includes graduation from the Royal Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALZECURE PHARMA AB 0,08% | 31/12/2025 | 107 302 ( 0,08% ) | 68 386 $ | 31/07/2026 |
Postes actifs de Ragnar Linder
| Sociétés | Poste | Début |
|---|---|---|
| ALZECURE PHARMA AB | Directeur/Membre du Conseil | 01/01/2017 |
| PERPETUA MEDICAL AB | Directeur/Membre du Conseil | 01/01/2019 |
3D Trace AB | Directeur/Membre du Conseil | - |
Tegnér Biotech Consulting AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Ragnar Linder
| Sociétés | Poste | Fin |
|---|---|---|
Amgen AB
 Amgen AB BiotechnologyHealth Technology Operates as biotechnology company which develops drugs related to cardiovascular and cancer drugs | Directeur Général | 01/01/2005 |
R Linder Holding AB | Directeur/Membre du Conseil | - |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Directeur/Membre du Conseil | - |
| ASARINA PHARMA AB | Directeur/Membre du Conseil | - |
Pygargus AB
 Pygargus AB Miscellaneous Commercial ServicesCommercial Services Provides market research and consulting services for the pharmaceutical sector | Fondateur | - |
Formation de Ragnar Linder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Newron Pharmaceuticals SpA
 Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perpetua Medical AB
 Perpetua Medical AB Electronic Equipment/InstrumentsElectronic Technology Manufactures pharmacological measurements systems | Electronic Technology |
Amgen AB
Amgen AB BiotechnologyHealth Technology Operates as biotechnology company which develops drugs related to cardiovascular and cancer drugs | Health Technology |
Pygargus AB
Pygargus AB Miscellaneous Commercial ServicesCommercial Services Provides market research and consulting services for the pharmaceutical sector | Commercial Services |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
AlzeCure Pharma AB
 AlzeCure Pharma AB BiotechnologyHealth Technology Engages in research, development, manufacture and sale of pharmaceutical products for neuro diseases | Health Technology |
R Linder Holding AB | |
3D Trace AB | |
Tegnér Biotech Consulting AB |
